tiprankstipranks

Mikael Dolsten Insider Profile

18 Followers
Mikael Dolsten, President R&D at Pfizer, holds 5.71K shares in Agilent (Ticker: A), holds 323.71K shares in Pfizer (Ticker: PFE), holds 0.00 shares in Karyopharm Therapeutics (Ticker: KPTI).
tipranks
Mikael Dolsten

Mikael Dolsten
Pfizer (PFE)
President R&D

Ranked #66,020 out of 97,825 Corporate Insiders

Profitable Transactions

33%
4 out of 12 Profitable Transactions

Average Return

-5.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
91.44%
8.56%
0.00%
A breakdown of Mikael Dolsten's holdings

Insider Roles

Pfizer
(PFE)
President R&D
Agilent
(A)
Director
Karyopharm Therapeutics
(KPTI)
Director
Roles that Mikael Dolsten holds in companies

Most Profitable Insider Trade

Stock:
Pfizer
(PFE)
Rating:Informative Sell
Date:Mar 06, 2015 - Mar 06, 2016
Return:+9.50%
The most profitable trade made by Mikael Dolsten

Mikael Dolsten's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Pfizer
Feb 29, 2024
President R&D
Uninformative Sell
579.66K
$8.99M
Agilent
Mar 19, 2024
Director
Uninformative Buy
247.47K
$841.63K
Karyopharm Therapeutics
Director
$0.00
List of latest transactions for each holding click on a transaction to see Mikael Dolsten's performance on stock

Mikael Dolsten insider profile FAQ

What is the percentage of profitable transactions made by Mikael Dolsten?
The percentage of profitable transactions made by Mikael Dolsten is 33%.
    What is the average return per transaction made by Mikael Dolsten?
    The average return per transaction made by Mikael Dolsten is -5.90%.
      What stocks does Mikael Dolsten hold?
      Mikael Dolsten holds: PFE, A, KPTI stocks.
        What was Mikael Dolsten’s latest transaction?
        Mikael Dolsten latest transaction was an Uninformative Buy of $247.47K.
          What was Mikael Dolsten's most profitable transaction?
          Mikael Dolsten’s most profitable transaction was an Informative Sell of PFE stock on March 6, 2015. The return on the trade was 9.50%.
            What is Mikael Dolsten's role in Pfizer?
            Mikael Dolsten's role in Pfizer is President R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.